Leung Li

Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials

Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway

Value of early evaluation of treatment response using 18F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma

Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies

Nasopharyngeal carcinoma

Hepatocellular carcinoma

Disease Burden of Hepatocellular Carcinoma: A Global Perspective

Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial

Global burden of liver disease: 2023 update

Macrophage M1/M2 polarization

Hepatocellular carcinoma

High CYP2E1 activity aggravates hepatofibrosis by limiting macrophage polarization towards the M2 phenotype

Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma

Prospective evaluation of plasma Epstein–Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma

Value of quality of life analysis in liver cancer: A clinician’s perspective

Colorectal cancer in Chinese patients: current and emerging treatment options

Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma – clinical application of health-related quality-of-life data

Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response

Applicability of BALAD score in prognostication of hepatitis B‐related hepatocellular carcinoma